PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsTelbermin
Telbermin
Telbermin is a protein pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
683 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Macular degenerationD008268EFO_0001365H35.30—123511
Choroidal neovascularizationD020256—————112
Wet macular degenerationD057135EFO_0004683————112
HemorrhageD006470MP_0001914R58———1—1
Vascular diseasesD014652EFO_0004264I77———1—1
Polypoidal choroidal vasculopathyD000092342—————1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Macular edemaD008269———12—36
EdemaD004487—R60.9—12—25
Retinal vein occlusionD012170EFO_1001157H34.81——2—24
Neoplasm metastasisD009362EFO_0009708—111——2
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369—C8011———1
SarcomaD012509———1———1
Gastrointestinal stromal tumorsD046152EFO_0000505C49.A—1———1
LeukemiaD007938—C9511———1
Myelodysplastic syndromesD009190—D4611———1
Myeloid leukemia acuteD015470—C92.011———1
Myeloid leukemiaD007951—C9211———1
Hepatocellular carcinomaD006528—C22.0—1———1
Liver neoplasmsD008113EFO_1001513C22.0—1———1
Colorectal neoplasmsD015179———1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
InfertilityD007246EFO_0000545—1————1
Healthy volunteers/patients———1————1
Renal cell carcinomaD002292EFO_0000376—1————1
CarcinomaD002277—C80.01————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MyopiaD009216EFO_0003927H52.1————11
Retinal neovascularizationD015861—H35.05————11
Pathologic neovascularizationD009389——————11
Caregiver burdenD000084802——————11
Eye diseasesD005128EFO_0003966H44————11
UveitisD014605EFO_1001231H20.9————11
InflammationD007249MP_0001845—————11
EndophthalmitisD009877——————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTelbermin
INNtelbermin
Description
Telbermin is a protein pharmaceutical. It is currently being investigated in clinical studies.
Classification
Protein
Drug classgrowth factors: vascular endothelial growth factors
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL2108557
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID22G76ZW50X (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 8,090 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use